GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-23 12:34:56 ET
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call February 23, 2026 8:30 AM EST
Company Participants
Sabrina Dunbar
Katherine Stueland - President, CEO & Director
Kevin Feeley - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx Holdings Corp.
NASDAQ: WGS
WGS Trading
1.15% G/L:
$91.445 Last:
203,179 Volume:
$94.87 Open:
WGS Latest News
March 10, 2026 08:30:00 am
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
March 09, 2026 08:30:00 am
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity(TM) and Real-World Genomic Leadership
February 26, 2026 05:00:14 pm
GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell?
WGS Stock Data
$2,739,577,040
20,348,831
0.11%
111
N/A
Medical Diagnostics & Screening
Healthcare
US
Stamford
